News

BioStat® Research
& Development Centre

2025 2024 2023 older
Biostat with EcoVadis CSR Certificate
08
July
2025
Biostat with EcoVadis CSR Certificate
The Biostat Research and Development Center has received the EcoVadis certification and the Silver Medal. EcoVadi...
New AI Solutions in Medfile
28
May
2025
New AI Solutions in Medfile
The Biostat development team is constantly enhancing the Medfile software for managing medical facilities. Recently, ...
Patient Assistant. Another AI-Based Solution in Medfile
06
February
2025
Patient Assistant. Another AI-Based Solution in Medfile
Patient Assistant is another AI-based solution in Medfile, following Drug Assistant. Thanks to this feature, patients...
6 million users of Medfile and HaloDoctor medical services
08
January
2025
6 million users of Medfile and HaloDoctor medical services
Nearly 6 million unique users visited the health websites Medfile.pl and HaloDoctor.pl, published by Biostat. Both po...
21
April
2017
21
April
2017

Study of Poland's investment attractiveness

Together with AHK Poland we conducted a study on the attractiveness of investment in Poland in 2017!

A conference where we presented the results and conclusions took place yesterday.

Together with AHK Poland we conducted a study on the attractiveness of investment in Poland in 2017!

A conference where we presented the results and conclusions took place yesterday.

Poland attracts foreign investors with its highly qualified workers, wide availability of subcontractors and its membership in the European Union. Poland’s biggest issue is its political and social stability – or rather lack thereof – and thus, a very difficult to assess economic policy – these are the results of the 12th edition of the Business-Politics Survey of the Polish-German Chamber of Commerce and Industry, conducted in cooperation with thirteen bilateral chambers in Poland, affiliated within the International Group of Chambers of Commerce. The study involved 369 foreign companies operating in Poland.

 

>Learn more about Biostat's market research services

Copyright© 2023 Biostat